Diabetes/ Diabetes/ News/ News/ Patients FDA warns of genital gangrene risk with diabetes drug class Piotr Wnuk Diabetes, FDA warning, SGLT2 inhibitors 0 Comment The US regulator released an official risk warning of a rare genital infection identified in 12 patients, including Share X FDA warns of genital gangrene risk with diabetes drug class https://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/
